FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904221640> ?p ?o ?g. }

• W2904221640 abstract "The value of assessing tumor infiltrating lymphocytes (TILs) in estrogen receptor (ER) positive/human epidermal growth factor receptor type 2 (HER2) negative breast cancer has yet to be determined. In the present study, a total of 184 cases with early distant recurrence detected within 5 years following the primary operation, 134 with late distant recurrence diagnosed following 5 years or longer and 321 controls without recurrence for >10 years following starting the initial treatment for ER‑positive/HER2 negative breast cancer, registered in 9 institutions, were analyzed. The distributions of TILs and their clinical relevance were investigated. TIL distributions did not differ significantly among the early, late and no recurrence groups, employing a 30% cut‑off point as a dichotomous variable. In those who had received adjuvant chemotherapy as well as endocrine therapy, a trend toward higher TIL proportions was detected when the early recurrence group was compared with the no recurrence group employing the 30% cut‑off point (P=0.064). The TIL distributions were significantly associated with nodal metastasis (P=0.004), ER status (P=0.045), progesterone receptor (PgR) status (P=0.002), tumor grade (P=0.021), and the Ki67 labeling index (LI) (P=0.002) in the no recurrence group and with the Ki67 LI in the recurrence groups (P=0.002 in early recurrence group, P=0.023 in late recurrence group). High TIL distributions also predicted shorter survival time following the detection of recurrence (P=0.026). However, these prognostic interactions were not significant in multivariate analysis (P=0.200). The present retrospective study demonstrated no significant interaction between TIL proportions and the timing of recurrence. However, higher TIL proportions were observed in breast cancer patients with aggressive biological phenotypes, which tended to be more responsive to chemotherapy. The clinical relevance of stromal TILs for identifying patients who would likely benefit from additional therapies merits further investigation in a larger patient population." @default.
• W2904221640 created "2018-12-22" @default.
• W2904221640 creator A5002884489 @default.
• W2904221640 creator A5005262997 @default.
• W2904221640 creator A5008946028 @default.
• W2904221640 creator A5009237974 @default.
• W2904221640 creator A5011041663 @default.
• W2904221640 creator A5011801222 @default.
• W2904221640 creator A5035390155 @default.
• W2904221640 creator A5047235156 @default.
• W2904221640 creator A5058192089 @default.
• W2904221640 creator A5065803170 @default.
• W2904221640 creator A5067189124 @default.
• W2904221640 creator A5070884525 @default.
• W2904221640 creator A5072654198 @default.
• W2904221640 creator A5078426460 @default.
• W2904221640 creator A5080772866 @default.
• W2904221640 creator A5087541425 @default.
• W2904221640 creator A5089549790 @default.
• W2904221640 date "2018-12-19" @default.
• W2904221640 modified "2023-10-13" @default.
• W2904221640 title "Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor‑positive/human epidermal growth factor receptor type 2 negative breast cancer" @default.
• W2904221640 cites W1862369714 @default.
• W2904221640 cites W1938027614 @default.
• W2904221640 cites W1966186646 @default.
• W2904221640 cites W2006070721 @default.
• W2904221640 cites W2028240776 @default.
• W2904221640 cites W2039787717 @default.
• W2904221640 cites W2098683355 @default.
• W2904221640 cites W2106610495 @default.
• W2904221640 cites W2112434826 @default.
• W2904221640 cites W2120431466 @default.
• W2904221640 cites W2121505284 @default.
• W2904221640 cites W2125885282 @default.
• W2904221640 cites W2134878729 @default.
• W2904221640 cites W2146817656 @default.
• W2904221640 cites W2154142993 @default.
• W2904221640 cites W2157058802 @default.
• W2904221640 cites W2169914436 @default.
• W2904221640 cites W2182062247 @default.
• W2904221640 cites W2340735966 @default.
• W2904221640 cites W2407664560 @default.
• W2904221640 cites W2468483329 @default.
• W2904221640 cites W2469830508 @default.
• W2904221640 cites W2470345540 @default.
• W2904221640 cites W2474898321 @default.
• W2904221640 cites W2516494390 @default.
• W2904221640 cites W2519727073 @default.
• W2904221640 cites W2526031077 @default.
• W2904221640 cites W2528841985 @default.
• W2904221640 cites W2542454476 @default.
• W2904221640 cites W2559561655 @default.
• W2904221640 cites W2560367415 @default.
• W2904221640 cites W2569158635 @default.
• W2904221640 cites W2580900639 @default.
• W2904221640 cites W2582908162 @default.
• W2904221640 cites W2590179977 @default.
• W2904221640 cites W2595028510 @default.
• W2904221640 cites W2596003372 @default.
• W2904221640 cites W2754197885 @default.
• W2904221640 cites W2755450690 @default.
• W2904221640 cites W2761177724 @default.
• W2904221640 cites W2762153201 @default.
• W2904221640 cites W2766888734 @default.
• W2904221640 cites W2769385365 @default.
• W2904221640 cites W2770323377 @default.
• W2904221640 cites W2771978163 @default.
• W2904221640 cites W2773608260 @default.
• W2904221640 cites W2783179377 @default.
• W2904221640 cites W2804249484 @default.
• W2904221640 cites W2844479918 @default.
• W2904221640 doi "https://doi.org/10.3892/ol.2018.9853" @default.
• W2904221640 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6341802" @default.
• W2904221640 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30675282" @default.
• W2904221640 hasPublicationYear "2018" @default.
• W2904221640 type Work @default.
• W2904221640 sameAs 2904221640 @default.
• W2904221640 citedByCount "17" @default.
• W2904221640 countsByYear W29042216402019 @default.
• W2904221640 countsByYear W29042216402020 @default.
• W2904221640 countsByYear W29042216402021 @default.
• W2904221640 countsByYear W29042216402022 @default.
• W2904221640 countsByYear W29042216402023 @default.
• W2904221640 crossrefType "journal-article" @default.
• W2904221640 hasAuthorship W2904221640A5002884489 @default.
• W2904221640 hasAuthorship W2904221640A5005262997 @default.
• W2904221640 hasAuthorship W2904221640A5008946028 @default.
• W2904221640 hasAuthorship W2904221640A5009237974 @default.
• W2904221640 hasAuthorship W2904221640A5011041663 @default.
• W2904221640 hasAuthorship W2904221640A5011801222 @default.
• W2904221640 hasAuthorship W2904221640A5035390155 @default.
• W2904221640 hasAuthorship W2904221640A5047235156 @default.
• W2904221640 hasAuthorship W2904221640A5058192089 @default.
• W2904221640 hasAuthorship W2904221640A5065803170 @default.
• W2904221640 hasAuthorship W2904221640A5067189124 @default.
• W2904221640 hasAuthorship W2904221640A5070884525 @default.
• W2904221640 hasAuthorship W2904221640A5072654198 @default.
• W2904221640 hasAuthorship W2904221640A5078426460 @default.
• W2904221640 hasAuthorship W2904221640A5080772866 @default.
• W2904221640 hasAuthorship W2904221640A5087541425 @default.

• next